PMAIP1 emerged as a novel pro-cancer factor in FTC, and its knockdown significantly inhibited the proliferation and metastasis of FTC both in vivo and in vitro. The gene discussed is PMAIP1; the disease is thyroid cancer, nonmedullary, 2.